ST2+ Tregs exhibited the most significant reduction compared with other immune cells in HBV+DEN-treated Il33KO versus WT liver at 4 months post-infection (Fig. 3e and Supplementary Fig. 4b). The gene discussed is IL1RL1; the disease is infection.